Neutropenia and efficacy outcomes in patients with refractory mCRC: A post-hoc analysis of the phase III SUNLIGHT trial

被引：0
|
作者：
Prager, G. [1 ]
Tabernero, J. [2 ]
Fakih, M. [3 ]
Ciardiello, F. [4 ]
Van Cutsem, E. [5 ]
Roby, L. [6 ]
Yao, W. [7 ]
Choucair, E. [8 ]
Taieb, J. [9 ]
机构：
[1] Univ Kliniken MedUni Wien AKH Wien, Dept Med 1, Vienna, Austria
[2] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
[3] City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA
[4] Univ Campania Luigi Vanvitelli, Dipartimento Med Precis, Naples, Italy
[5] UZ Leuven Univ Hosp Leuven, Digest Oncol Dept, Campus Gasthuisberg, Leuven, Belgium
[6] IRIS, Dept Oncol, Suresnes, France
[7] Servier Pharmaceut, Dept Clin Res, Boston, MA USA
[8] Lab Servier SAS, Med Affairs, Suresnes, France
[9] Hop European George Pompidou, Gastroenterol & Digest Oncol Dept, Paris, France
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
35P
引用
收藏
页码：S18 / S19
页数：2
相关论文
共 50 条
  • [21] Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial
    Yu Hu
    Yang, Renchi
    Ting Niu
    Heng Mei
    Liu Xiaofan
    Yan Li
    Hu Zhou
    Ying Feng
    Gao, Guangxun
    Peng Cheng
    Huang, Ruibin
    Yang, Linhua
    Hu, Jianda
    Ming Hou
    Yao, Yazhou
    Li Liu
    Yi Wang
    Wu, De-Pei
    Shen, Xuliang
    Jie Jin
    Luo, Jianmin
    Zeng Yun
    Xin Zhou
    Xiang, Ruixiang
    Jiang, Zhongxing
    Bai, Yuansong
    Xiong, Junye
    Li, Runzi
    Zou, Jianjun
    BLOOD, 2022, 140 : 5543 - 5545
  • [22] Efficacy of OnabotulinumtoxinA among diverse racial/ethnic groups: post-hoc analysis of the phase 4 COMPEL trial
    Blumenfeld, A.
    Charleston, L.
    Sommer, K.
    O'Brien, H. L.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [23] Pirfenidone Delays the Prescription of Concomitant Drugs in Patients with Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Japanese Phase III Clinical Trial
    Suzuki, A.
    Sakaguchi, H.
    Ebina, M.
    Azuma, A.
    Ogura, T.
    Taguchi, Y.
    Suga, M.
    Takahashi, H.
    Sugiyama, Y.
    Kudoh, S.
    Nukiwa, T.
    Miyazawa, S.
    Sakamoto, K.
    Kondoh, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder (OAB): Post-hoc analysis of a prospective, randomised European-Australian phase III trial
    Khullar, V
    Cambronero, J.
    Angulo, J.
    Wooning, M.
    Blauwet, M. B.
    Dorrepaal, C.
    Martin, N. E.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E684 - U460
  • [25] Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies
    Ana-Maria Orbai
    Philip J. Mease
    Philip S. Helliwell
    Oliver FitzGerald
    Dona L. Fleishaker
    Rajiv Mundayat
    Pamela Young
    BMC Rheumatology, 6
  • [26] Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications
    Zhang, Yi
    Zhou, Hu
    Suo, Shanshan
    Zhuang, Junling
    Yang, Linhua
    He, Aili
    Liu, Qingchi
    Du, Xin
    Gao, Sujun
    Li, Yarong
    Li, Yan
    Chen, Yuqing
    Wu, Wen
    Zhu, Huanling
    He, Guangsheng
    Hong, Mei
    Jiang, Qian
    Jiang, Zhongxing
    Jing, Hongmei
    Wang, Jishi
    Xu, Na
    Yue, Lingling
    Zheng, Cuiping
    Zhou, Zeping
    Jin, Chenghao
    Li, Xin
    Liu, Lin
    Xu, Yajing
    Wu, Dengshu
    Zhang, Feng
    Zhang, Jin
    Xiao, Zhijian
    Jin, Jie
    BLOOD, 2024, 144 : 3165 - 3166
  • [27] Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies
    Orbai, Ana-Maria
    Mease, Philip J.
    Helliwell, Philip S.
    FitzGerald, Oliver
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela
    BMC RHEUMATOLOGY, 2022, 6 (01)
  • [28] Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial
    Kontoyiannis, Dimitrios P.
    Selleslag, Dominik
    Mullane, Kathleen
    Cornely, Oliver A.
    Hope, William
    Lortholary, Olivier
    Croos-Dabrera, Rodney
    Lademacher, Christopher
    Engelhardt, Marc
    Patterson, Thomas F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (03) : 757 - 763
  • [29] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
    Kim, Byung-Kun
    Cho, Soo-Jin
    Han, Jeong Hee
    Dell'Agnello, Grazia
    Panni, Tommaso
    Kim, Manho
    Oh, Kyungmi
    Moon, Heui-Soo
    Chu, Min Kyung
    JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05): : 483 - 494
  • [30] The Burden of White Matter Hyperintensities on Function Outcomes in Patients Treated for Acute Ischemic Stroke: A Post-Hoc Analysis of the IMS-III Trial
    Mehta, Amit
    Elmashad, Ahmed
    Narula, Reshma
    Broderick, Joseph P.
    de Havenon, Adam H.
    STROKE, 2024, 55
12345